Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-37,472
Closed -$10.7M 6
2024
Q1
$10.7M Sell
37,472
-15,370
-29% -$4.5M 0.56% 48
2023
Q4
$15.2M Sell
52,842
-35,908
-40% -$9.78M 0.9% 39
2023
Q3
$23.9M Buy
88,750
+70,602
+389% +$17.6M 0.8% 45
2023
Q2
$4.03M Buy
+18,148
New +$4.21M 0.13% 61

Other funds holding AMGN

Wafra Inc's AMGN Position: Q2 2024 in Review

Wafra Inc sold out of Amgen (AMGN) in Q2 2024, closing a stake of 37,472 shares — an estimated $10.7M sold.

Wafra Inc first reported a position in AMGN in Q2 2023 and held it in 4 quarters. The position peaked at $23.9M in Q3 2023. 2,785 funds tracked by Wall St. Rank hold AMGN as of Q2 2024.

  • Wafra Inc reported no remaining Amgen position as of Q2 2024 after selling out during the quarter.
  • Wafra Inc sold 37,472 Amgen shares in Q2 2024, an estimated $10.7M.
  • Wafra Inc first reported a position in Amgen in Q2 2023 and held it in 4 quarters.
  • Wafra Inc's Amgen position peaked at $23.9M in Q3 2023.
  • 2,785 funds tracked by Wall St. Rank held Amgen as of Q2 2024.

Based on Wafra Inc's 13F filing for Q2 2024, filed 5 Aug 2024.